Skip to content

← All stories

Markets

Climb Bio reports phase 1 data for IgA nephropathy drug

1 source ·1 article ·2h ago Climb Bio

Covered by 1 outlet

All coverage · 1 article

Investing.com UK ·2h ago

Climb Bio reports phase 1 data for IgA nephropathy drug